Trials of Deep TMS treatment by Israel’s Brainsway at Sheba Medical Center have shown a 27 percent improvement in patients with Obsessive Compulsive Disorder. These were OCD patients that had previously failed to respond to both pharmacological and psychological therapy. … Continue reading →

The US FDA has approved the use of the Deep Transcranial Magnetic Stimulation (TMS) system from Israel’s BrainsWay (see here) to treat cigarette smokers who seek to quit. The patient wears a helmet containing a patented H-coil that generates a … Continue reading →

Israeli companies HeartBeat Technologies and Brainsway have been selected for a joint Israel-Canada partnership program. They will test their innovative aging and brain health solutions at two Canadian seniors care organizations. https://globenewswire.com/news-release/2018/01/08/1285341/0/en/Two-Israeli-Firms-Selected-to-Test-Their-Aging-and-Brain-Health-Innovations-at-Ontario-Seniors-Care-Organizations.html http://www.heartbeattec.com/ http://israelactive.com/?s=Brainsway

The UN Navy has ordered several Deep TMS therapy helmets made by Israel’s Brainsway. Deep Transcranial Magnetic Stimulation will treat service personnel with a range of psychological conditions, including post-traumatic stress disorder (PTSD) and major depressive disorder. http://www.timesofisrael.com/us-navy-buys-israeli-brain-zapper-to-treat-vets/

Israel’s Brainsway has now installed 101 Deep Transcranial Magnetic Stimulation devices worldwide – 50% in the USA and has orders for another 36.  Brainsways depression-treatment service using DTMS is covered by the insurance policies of 193 million people in the … Continue reading →

Israel’s Brainsway has installed its Deep Brain Transcranial Magnetic Stimulation (TMS) systems at Stockholm’s Karolinska University Hospital where they will be used immediately to treat patients with depression. Sweden has one of the highest rates of depression in the world. … Continue reading →

Brainsway’s Deep TMS (transcranial magnetic stimulation) device can make a significant improvement to those suffering from severe depression. In trials on 250 patients, 30.4% of the patients treated with Deep TMS achieved remission, compared with 14.5% of the control group. … Continue reading →

Israel’s Brainsway reported positive final results in a clinical trial of its Deep TMS (transcanial magnetic stimulation) device for opening of the blood brain barrier in patients with malignant brain tumours. This is important for chemotherapy, and new therapies, in … Continue reading →